MedTrace Logo

Analgetic Effect of Preoperative Pregabalin in Patients Undergoing Nephrectomy

NCT00957177 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2011-05-27

No results posted yet for this study

Summary

Pregabalin 300mg or placebo are administered 1 hour preoperatively in patients undergoing elective nephrectomy. Postoperatively, patients receive a patient controlled analgesia device for self delivering opioids. Morphine consumption in the first 48 hours is documented.

Hyperalgesia is measured by von-Frey-Filaments.

Conditions

  • Postoperative Pain

Interventions

DRUG

Pregabalin

300mg pregabalin orally 1 hour before operation

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Andreas Sandner-Kiesling, MD · Medical University of Graz

  • Helmar Bornemann-Cimenti, MD, DSc · Graz Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00957177 on ClinicalTrials.gov